Heterogeneity in testing for infectious diseases

R Soc Open Sci. 2022 May 18;9(5):220129. doi: 10.1098/rsos.220129. eCollection 2022 May.

Abstract

Testing strategies have varied widely between nation states during the COVID-19 pandemic, in intensity as well as methodology. Some countries have mainly performed diagnostic testing while others have opted for mass-screening for the presence of SARS-CoV-2 as well. COVID passport solutions have been introduced, in which access to several aspects of public life requires either testing, proof of vaccination or a combination thereof. This creates a coupling between personal activity levels and testing behaviour which, as we show in a mathematical model, leverages heterogeneous behaviours in a population and turns this heterogeneity from a disadvantage to an advantage for epidemic control.

Keywords: COVID-19; SARS-CoV-2; mitigation; non-pharmaceutical interventions; screening; testing.

Associated data

  • figshare/10.6084/m9.figshare.c.5985992